Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme
Share: First-of-its-kind policy amendment will allow legal access to evidence-based treatments to those in need before formal drug approval VANCOUVER, BC, Dec. 11, 2020 /CNW/ - . ("Numinus" or the "Company") (TSXV:NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, commends Health Canada's leadership for its intention to revise the Special Access Programme (SAP) to permit access to MDMA and psilocybin-assisted psychotherapy. The intended SAP revision, anno...
Source: benzinga.com